Bath & Body Works (BBWI) Projected to Post Quarterly Earnings on Thursday

Bath & Body Works (NYSE:BBWI) is expected to be announcing its Q3 2026 results before the market opens on Thursday, November 20th. Analysts expect the company to announce earnings of $0.40 per share and revenue of $1.6405 billion for the quarter. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS.Interested persons may visit the the company’s upcoming Q3 2026 earningresults page for the latest details on the call scheduled for Thursday, November 20, 2025 at 8:30 AM ET.

Bath & Body Works (NYSE:BBWI) last issued its earnings results on Thursday, August 28th. The company reported $0.37 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.37. The company had revenue of $1.55 billion for the quarter, compared to analyst estimates of $1.55 billion. Bath & Body Works had a negative return on equity of 48.43% and a net margin of 9.88%.Bath & Body Works’s revenue for the quarter was down .8% on a year-over-year basis. During the same period in the prior year, the firm earned $0.37 earnings per share. On average, analysts expect Bath & Body Works to post $3 EPS for the current fiscal year and $4 EPS for the next fiscal year.

Bath & Body Works Price Performance

Shares of NYSE BBWI opened at $21.09 on Wednesday. The company has a 50-day moving average price of $25.21 and a 200-day moving average price of $28.39. The stock has a market capitalization of $4.35 billion, a P/E ratio of 6.26, a P/E/G ratio of 0.86 and a beta of 1.53. Bath & Body Works has a 1 year low of $20.85 and a 1 year high of $41.87.

Bath & Body Works Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 5th. Shareholders of record on Friday, November 21st will be paid a dividend of $0.20 per share. The ex-dividend date is Friday, November 21st. This represents a $0.80 annualized dividend and a yield of 3.8%. Bath & Body Works’s dividend payout ratio (DPR) is 23.74%.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on BBWI. Raymond James Financial restated a “market perform” rating on shares of Bath & Body Works in a report on Wednesday, November 12th. Barclays decreased their target price on Bath & Body Works from $32.00 to $28.00 and set an “equal weight” rating for the company in a research report on Monday, October 20th. Wells Fargo & Company lowered their price target on shares of Bath & Body Works from $44.00 to $33.00 and set an “overweight” rating on the stock in a research report on Monday, October 27th. Weiss Ratings restated a “hold (c-)” rating on shares of Bath & Body Works in a research report on Wednesday, October 8th. Finally, Citigroup decreased their price objective on shares of Bath & Body Works from $42.00 to $40.00 and set a “buy” rating on the stock in a research report on Tuesday, August 19th. Ten analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $38.18.

Institutional Trading of Bath & Body Works

Institutional investors and hedge funds have recently modified their holdings of the business. State of Wyoming raised its stake in shares of Bath & Body Works by 6.2% in the second quarter. State of Wyoming now owns 11,294 shares of the company’s stock worth $338,000 after purchasing an additional 661 shares during the last quarter. Vident Advisory LLC increased its holdings in Bath & Body Works by 2.8% in the 2nd quarter. Vident Advisory LLC now owns 25,229 shares of the company’s stock worth $756,000 after buying an additional 692 shares in the last quarter. Geneos Wealth Management Inc. raised its position in Bath & Body Works by 217.7% in the 1st quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock worth $35,000 after buying an additional 801 shares during the last quarter. Integrated Wealth Concepts LLC lifted its stake in Bath & Body Works by 13.4% during the 3rd quarter. Integrated Wealth Concepts LLC now owns 10,788 shares of the company’s stock valued at $278,000 after acquiring an additional 1,278 shares during the period. Finally, Advisory Services Network LLC bought a new position in Bath & Body Works during the 3rd quarter valued at about $48,000. Institutional investors own 95.14% of the company’s stock.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.